×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Jean-Emmanuel Kurtz (ICANS Strasbourg)

18:00
Introduction du partenariat avec le Cancéropôle
Rachel Groubet (Cancéropôle Est)
 
18:05
Les ADCs Anti-HER2, mécanismes d’action & de résistance et solutions d’après
Pr Sylvain Ladoire (CGFL Dijon)
 
18:20
Les inhibiteurs de tyrosine kinase Anti-HER2, classe thérapeutique à part entière, du mécanisme d’action à l’effet thérapeutique
Pr Thierry Petit (ICANS Strasbourg)
 
 
18:35
Cas clinique/Synthèse des stratégies thérapeutiques actuelles et perspectives
Dr Isabelle Desmoulins & Pr Sylvain Ladoire (CGFL Dijon)
 
18:50
Débat/Discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-10-13
Last update : 2022-10-14

Suggestions

Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
Honolulu : Thursday, December 2nd 2021 from 07am to 08am (GMT+1)
San Francisco : Thursday, December 2nd 2021 from 09am to 10am (GMT+1)
New York : Thursday, December 2nd 2021 from 12pm to 01pm (GMT+1)
Buenos Aires : Thursday, December 2nd 2021 from 02pm to 03pm (GMT+1)
London / Dublin : Thursday, December 2nd 2021 from 05pm to 06pm (GMT+1)
Paris / Berlin : Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
Istanbul : Thursday, December 2nd 2021 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Thursday, December 2nd 2021 from 09pm to 10pm (GMT+1)
Bangkok : Friday, December 3rd 2021 from 12am to 01am (GMT+1)
Shanghai : Friday, December 3rd 2021 from 01am to 02am (GMT+1)
Tokyo : Friday, December 3rd 2021 from 02am to 03am (GMT+1)
Sydney : Friday, December 3rd 2021 from 03am to 04am (GMT+1)
Wellington : Friday, December 3rd 2021 from 05am to 06am (GMT+1)

SLNB or TAD after NAC in cN1 / ycN0 patients

Share
Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 21st 2021 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, December 21st 2021 from 09am to 10:30am (GMT+1)
New York : Tuesday, December 21st 2021 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, December 21st 2021 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 21st 2021 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, December 22nd 2021 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, December 22nd 2021 from 05am to 06:30am (GMT+1)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Honolulu : Tuesday, March 28th 2023 from 08am to 09:30am (GMT+2)
San Francisco : Tuesday, March 28th 2023 from 11am to 12:30pm (GMT+2)
New York : Tuesday, March 28th 2023 from 02pm to 03:30pm (GMT+2)
Buenos Aires : Tuesday, March 28th 2023 from 03pm to 04:30pm (GMT+2)
Reykjavik : Tuesday, March 28th 2023 from 06pm to 07:30pm (GMT+2)
London / Dublin : Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Paris / Berlin : Tuesday, March 28th 2023 from 08pm to 09:30pm (GMT+2)
Istanbul : Tuesday, March 28th 2023 from 09pm to 10:30pm (GMT+2)
Moscou / Dubaï : Tuesday, March 28th 2023 from 10pm to 11:30pm (GMT+2)
Bangkok : Wednesday, March 29th 2023 from 01am to 02:30am (GMT+2)
Shanghai : Wednesday, March 29th 2023 from 02am to 03:30am (GMT+2)
Tokyo : Wednesday, March 29th 2023 from 03am to 04:30am (GMT+2)
Sydney : Wednesday, March 29th 2023 from 05am to 06:30am (GMT+2)
Wellington : Wednesday, March 29th 2023 from 07am to 08:30am (GMT+2)

La prise en charge des cancers du sein triple négatifs :

intégration des innovations thérapeutiques dans les algorithmes et gestion des effets secondaires

Share
Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, May 14th 2024 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, May 14th 2024 from 10am to 11:30am (GMT+2)
New York : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, May 14th 2024 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, May 14th 2024 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, May 15th 2024 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, May 15th 2024 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, May 15th 2024 from 06am to 07:30am (GMT+2)

Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Scroll Up